Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

2017; Elsevier BV; Volume: 4; Issue: 7 Linguagem: Inglês

10.1016/s2352-3026(17)30088-1

ISSN

2451-9960

Autores

Claire Harrison, Nicolaas Schaap, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Ramón V. Tiu, Pierre Zachée, Éric Jourdan, Elliott F. Winton, Richard T. Silver, Harry C. Schouten, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Joanne Lager, Zhenming Shun, Ruben A. Mesa,

Tópico(s)

Eosinophilic Disorders and Syndromes

Referência(s)